Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial

Introduction: Early-onset type 2 diabetes mellitus is characterized by higher exposure to cardiometabolic risk throughout life and increased risk of cardiovascular morbidity. GLP-1 receptor agonists and SGLT2 inhibitors improve the markers of cardiometabolic risk; however, a comparison between the...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Marriam Abid, Samia Gull Akhtar, Tabinda Razzaq, Zia Ullah, Shah Abdul Latif, Hafiz Muhammad Qasim, Muhammad Abbas Sadiq
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Link Medical Interface 2026-06-01
Serie:	Link Medical Journal of Health and Community Research
Soggetti:	Cardiovascular Risk Markers, Early-Onset Diabetes, GLP-1 Receptor Agonists, Glycated Hemoglobin, Lipid Profile, SGLT2 Inhibitors, Type 2 Diabetes Mellitus.
Accesso online:	https://linkmjhcr.com/index.php/lmj/article/view/189
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!